Abstract
While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-activates transcription. We integrated ChIP-seq and RNA-seq data to identify menin target genes. Our analysis revealed that menin-dependent target gene promoters display looping to distal enhancers that are bound by menin, FOXA1 and GATA3. In this fashion, MEN1 co-regulates a proliferative breast cancer-specific gene expression program in ER+ cells. In primary mammary cells, MEN1 exerts an anti-proliferative function by regulating a distinct expression signature. Our findings clarify the cell-type-specific functions of MEN1 and inform the development of menin-directed treatments for breast cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 2359-2372 |
| Number of pages | 14 |
| Journal | Cell Reports [E] |
| Volume | 18 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 7 Mar 2017 |
Keywords
- breast cancer
- enhancer
- epigenetics
- histone H3K4 trimethylation
- MEN1
- menin
- oncogene
- transcription
- tumor suppressor
Fingerprint
Dive into the research topics of 'Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver